Dicarboxylic aminoaciduria is a rare genetic condition that affects how the kidneys handle certain amino acids. People with Dicarboxylic aminoaciduria often have no symptoms, but some may have mild fatigue or poor growth in childhood. Features can include higher levels of aspartic and glutamic acids in urine, which doctors find on testing. It is lifelong, and most people live normal lifespans. Treatment is usually not needed, but nutrition support and regular follow‑up can help when issues arise.
Overview
Dicarboxylic aminoaciduriaSymptoms
Dicarboxylic aminoaciduria is often silent. Many people have no noticeable features, and the condition is usually discovered on urine tests showing high glutamate and aspartate losses. Rare reports mention developmental or neurologic concerns, but these links remain unclear.
Outlook and prognosis
Many people with Dicarboxylic aminoaciduria stay well and have a normal life span, especially when it’s found incidentally. When symptoms occur, they’re usually mild—such as occasional kidney stone risk or growth concerns—managed with monitoring, hydration, and nutrition guidance. Regular follow-up helps prevent complications.
Causes and risk factors
Dicarboxylic aminoaciduria results from inherited changes in the SLC1A1 gene, usually autosomal recessive and present from birth. Risk increases with family history or parents who are related by blood. Illness, dehydration, or high-protein intake may influence severity, not cause.
Genetic influences
Genetics are central in Dicarboxylic aminoaciduria; it’s an inherited condition caused by changes in a gene that transports certain amino acids in the kidneys. Variants are usually passed in an autosomal recessive pattern. Genetic testing can confirm the diagnosis and guide family counseling.
Diagnosis
Dicarboxylic aminoaciduria is usually found after abnormal urine amino acid screening shows high aspartate and glutamate losses. Quantitative urine studies confirm the pattern. Genetic diagnosis of Dicarboxylic aminoaciduria uses testing for SLC1A1 or related transporter genes, with studies as needed.
Treatment and drugs
Treatment for dicarboxylic aminoaciduria focuses on managing high levels of certain amino acids and supporting nutrition. Care often includes a protein‑controlled diet guided by a metabolic dietitian, good hydration, and monitoring growth and kidney health. Some may benefit from targeted amino acid adjustments and periodic urine and blood checks.
Symptoms
Dicarboxylic aminoaciduria is a rare inherited condition where the kidneys pass extra amounts of two amino acids into the urine. Most people feel well and notice no day-to-day problems, and it’s often found during lab testing done for other reasons. Features vary from person to person and can change over time. When present, early features of Dicarboxylic aminoaciduria may include developmental delays or seizures in childhood, though this is uncommon.
Many people feel completely well and have no day-to-day problems. The condition is usually discovered on urine testing rather than by how someone feels.
Higher levels of certain amino acids are found in urine. This lab finding is typical of dicarboxylic aminoaciduria and does not usually cause pain, burning, or other urinary changes. It’s simply a marker of how the kidneys handle these amino acids.
A small number of reports describe mild learning or developmental delays. For a child, this might look like taking longer to pick up new skills or school tasks. Because many conditions can cause this, clinicians look broadly during evaluation.
Seizures have been noted in a few people living with dicarboxylic aminoaciduria. They can include brief staring spells or more obvious shaking events. An evaluation helps rule out other, more common causes.
How people usually first notice Dicarboxylic aminoaciduria?
Many people first notice dicarboxylic aminoaciduria when a routine urine test done for another reason shows unusually high levels of certain amino acids such as aspartic and glutamic acid. In infancy or early childhood, doctors may spot the first signs of dicarboxylic aminoaciduria as persistent aminoaciduria on screening, sometimes alongside mild symptoms like poor appetite, vomiting, or slow weight gain, though many children feel well. In some families, how dicarboxylic aminoaciduria is first noticed comes through follow-up testing after an older sibling is diagnosed or after prenatal or newborn screening flags an atypical amino acid pattern.
Types of Dicarboxylic aminoaciduria
Dicarboxylic aminoaciduria is a rare genetic condition. It involves problems reabsorbing certain amino acids (like glutamate and aspartate) in the kidneys and, sometimes, the intestine. Clinicians often describe them in these categories: a classic form linked to the main transporter defect and a milder, secondary form from other kidney issues. The types of Dicarboxylic aminoaciduria can lead to different symptom patterns, from no symptoms to feeding issues or growth concerns in childhood.
Classic primary type
This variant is tied to a defect in the main kidney amino acid transporter that handles glutamate and aspartate. People with this type typically have high levels of these amino acids in urine, with symptoms ranging from none to mild feeding or growth issues. Some may also have loose stools or abdominal discomfort due to reduced intestinal reabsorption.
Secondary-like form
This describes dicarboxylic aminoacid loss that occurs as part of broader kidney tubule problems rather than a single transporter defect. Symptoms don’t always look the same for everyone. People may have other signs of tubular dysfunction, while the extra loss of glutamate and aspartate is one piece of the picture.
What genetics can tell you about symptoms
Certain SLC1A1 gene changes disrupt a kidney transporter that normally reabsorbs the amino acids aspartate and glutamate, so these spill into urine. People with specific variants may also have neuropsychiatric features like obsessive-compulsive symptoms, tics, or attention difficulties.
Causes and risk factors
Dicarboxylic aminoaciduria is caused by changes in the SLC1A1 gene that affect how the kidneys and intestines handle glutamate and aspartate. It usually follows an autosomal recessive pattern, so risk is higher when parents are related by blood. Family history raises risk, and testing may be considered before early symptoms of dicarboxylic aminoaciduria appear. Hydration, illness, kidney health, and high protein intake can change how much of these amino acids appear in urine, but they do not cause the disorder. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Dicarboxylic aminoaciduria is present from birth. Many families look for early symptoms of dicarboxylic aminoaciduria, but this section explains what in the environment or body might affect the chance of it occurring. Evidence is limited because the condition is very rare. Doctors often group risks into internal (biological) and external (environmental).
No proven link between specific environmental exposures and dicarboxylic aminoaciduria has been shown. Common pollutants, radiation, or workplace chemicals have not been found to raise its likelihood. Because the condition is rare, research remains limited.
Current data do not show that advanced maternal or paternal age changes the chance of this condition. Dicarboxylic aminoaciduria appears independent of parents’ ages.
Chronic conditions in the mother, such as diabetes, infections, or thyroid disease, have not been consistently tied to higher risk of dicarboxylic aminoaciduria. Available reports do not show a clear pattern.
Being born preterm, by cesarean, or with delivery complications does not appear to change the chance of having this condition. These factors may affect newborn health generally, but not the likelihood that dicarboxylic aminoaciduria is present.
Genetic risk factors
Dicarboxylic aminoaciduria is usually caused by changes in the SLC1A1 gene that affect how the body transports the amino acids glutamate and aspartate. It typically follows an autosomal recessive pattern, meaning two non-working copies are needed for the condition to appear and carriers usually have no symptoms. Because early symptoms of dicarboxylic aminoaciduria can be subtle or absent, family history and genetic testing often point the way. Some risk factors are inherited through our genes.
SLC1A1 variants: Changes in the SLC1A1 gene disrupt a transporter that moves glutamate and aspartate in kidney cells and other tissues. This gene-level problem is the direct cause of dicarboxylic aminoaciduria.
Autosomal recessive: The condition appears when two non-working SLC1A1 copies are inherited, one from each parent. If both parents are carriers, each pregnancy has a 25% (1 in 4) chance of being affected.
Carrier parents: Carriers usually stay healthy and may never know they carry a variant. When two carriers have a child together, the risk of dicarboxylic aminoaciduria in their children increases.
Family history: Having a sibling or close relative with a confirmed SLC1A1 change raises the chance you carry the same change. Targeted testing for a known family variant can clarify personal risk.
Parental relatedness: When parents are related by blood, they are more likely to share the same SLC1A1 variant. This raises the likelihood of a child inheriting two non-working copies.
Variant severity: Different SLC1A1 changes reduce transporter function by different amounts. This can influence how noticeable the condition’s features are from one person to another.
Lifestyle risk factors
Dicarboxylic aminoaciduria is a genetic condition; lifestyle habits do not cause it, but they can influence day-to-day symptoms and urinary amino acid losses. Here is a focused look at lifestyle risk factors for Dicarboxylic aminoaciduria and how lifestyle affects Dicarboxylic aminoaciduria. Evidence is limited due to the rarity of the condition, so changes should be individualized with your clinician.
Large protein loads boost glutamate and aspartate intake and filtration, which may raise urinary losses. Smaller, evenly spaced protein servings may reduce peaks in excretion.
Foods with monosodium glutamate or aspartame can increase glutamate/aspartate exposure, potentially amplifying transient plasma peaks. Some people report more headaches or neuro-sensory symptoms after such foods, though evidence is limited.
Low fluid intake concentrates urine, which may intensify urinary amino acid losses and irritative urinary symptoms. Regular hydration helps dilute excretion and is especially important during heat or illness.
Intercurrent illness, skipped meals, or prolonged fasting increase catabolism and can alter renal handling of amino acids. Avoiding long fasts and maintaining carbohydrate intake during illness may help stabilize levels.
Risk prevention
Dicarboxylic aminoaciduria is a rare inherited condition caused by changes in a gene that handles certain amino acids in the kidney and gut. There’s no way to prevent the condition itself, so prevention focuses on avoiding complications and planning for future pregnancies. Knowing your risks can guide which preventive steps matter most. Early symptoms of dicarboxylic aminoaciduria are often minimal or absent, which makes routine monitoring helpful.
Meet with a genetics professional to understand how dicarboxylic aminoaciduria runs in families. They can explain chances for future children and what testing can show.
If dicarboxylic aminoaciduria is in your family, a blood or saliva test can check who carries the gene change. This helps relatives make informed choices.
Talk about prenatal testing or IVF with embryo testing to lower the chance of having an affected child. A genetics specialist can outline benefits, limits, and timing.
Periodic urine and blood tests can track kidney handling of amino acids. Routine check-ups help catch any changes early.
Transmission
Dicarboxylic aminoaciduria is not an infection and cannot be caught or spread through everyday contact, saliva, or blood. It happens when a child inherits two nonworking copies of a gene that helps the kidneys handle certain amino acids; this pattern is called autosomal recessive inheritance.
Parents are usually healthy carriers. When both carry the change, each pregnancy has a 25% (1 in 4) chance of Dicarboxylic aminoaciduria, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance of neither; genetic counseling can help families understand how Dicarboxylic aminoaciduria is inherited and discuss carrier testing.
When to test your genes
Consider genetic testing if you or a child have persistently high urinary dicarboxylic amino acids on labs, unexplained developmental concerns, or a family history of Dicarboxylic aminoaciduria. Testing helps confirm the diagnosis, guide metabolic monitoring, and tailor nutrition and specialist care. It’s also useful for carrier testing and family planning.
Diagnosis
People living with Dicarboxylic aminoaciduria often feel well day to day, and it’s sometimes discovered when routine labs show unusual amino acid patterns. Many people feel relief just knowing what’s really going on. Doctors compare findings from urine and blood and then use genetic tests to confirm the cause. Understanding the diagnosis of Dicarboxylic aminoaciduria can also guide family planning and follow-up.
A detailed family and health history can help spot patterns that suggest an inherited amino acid handling issue. Your clinician may ask about kidney concerns, growth, past lab results, and whether any relatives had similar findings.
Most people have a normal exam, but the doctor will check overall health and signs that might point to kidney stress. This helps decide which tests to order first.
A urine test often shows high levels of certain dicarboxylic amino acids, especially aspartate and glutamate. Repeating the test on a fresh sample can confirm that the pattern is consistent.
Blood levels may be normal even when urine levels are high, which supports a kidney reabsorption problem rather than overproduction. Comparing urine and blood helps narrow the cause.
Stages of Dicarboxylic aminoaciduria
Dicarboxylic aminoaciduria does not have defined progression stages. For many, the condition stays fairly stable over time and is usually identified by characteristic findings on urine testing rather than a gradual worsening of symptoms. Different tests may be suggested to help confirm the diagnosis and rule out similar conditions. Doctors often use urine amino acid analysis, blood tests, and sometimes genetic testing; if early symptoms of dicarboxylic aminoaciduria are present—such as learning or movement concerns—these exams can help guide care.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Dicarboxylic aminoaciduria, everyday life is only mildly affected, and the condition may be found incidentally on urine testing rather than through obvious symptoms. Early symptoms of Dicarboxylic aminoaciduria can include frequent urination, bedwetting beyond the usual age, or episodes of dehydration during illness; some children outgrow these challenges as kidneys mature, while others continue to have intermittent issues. Many people find that symptoms come and go, often triggered by stress, fever, or not drinking enough fluids.
The outlook is not the same for everyone, but most reports suggest a generally favorable course with careful hydration and routine follow-up. Serious complications like kidney stones or kidney scarring appear uncommon, though they can happen if dehydration recurs or urinary acidity remains high for long periods. There’s no evidence that Dicarboxylic aminoaciduria shortens life expectancy on its own, and mortality directly due to the condition is not described in modern case series. Prognosis refers to how a condition tends to change or stabilize over time, and in Dicarboxylic aminoaciduria, the pattern often stays stable from childhood into adulthood.
With ongoing care, many people maintain good kidney health and lead active lives. Practical steps—staying well hydrated, treating fevers promptly, and checking urine tests when symptoms flare—can reduce setbacks. Talk with your doctor about what your personal outlook might look like, especially if you’ve had kidney stones, recurrent urinary infections, or other kidney concerns, since these can influence your long-term plan. Genetic testing can sometimes provide more insight into prognosis, because different gene changes may relate to how strongly the kidneys spill certain amino acids, but not everyone with the same gene change will have the same outlook.
Long-term effects
Dicarboxylic aminoaciduria is linked to a lifelong tendency to pass certain acidic amino acids into the urine. Many people feel well over time, and some never notice day-to-day changes. Many resources discuss early symptoms of Dicarboxylic aminoaciduria, but long-term features are often mild or absent. Long-term effects vary widely, and researchers are still learning which findings truly relate to this condition.
Extra glutamate and aspartate continue to appear in urine on lab tests. This finding often remains stable over the years. For many, it does not cause direct problems.
Most children and adults have typical growth and everyday functioning. A few reports note developmental differences, but these are not consistent across studies.
Some research has explored links with attention or compulsive traits, but a firm connection has not been proven. Many people have typical learning and school performance.
Kidney function is generally normal, and there is no clear pattern of kidney damage. Urine tests may repeatedly show these amino acids without other kidney changes.
How is it to live with Dicarboxylic aminoaciduria?
Living with dicarboxylic aminoaciduria is often quiet and routine because many people have no noticeable symptoms and discover it only through lab testing. For some, there may be mild issues like occasional fatigue or headaches, and urine tests can show high levels of certain amino acids, which a clinician may monitor over time. Daily life usually doesn’t need major changes, though staying well hydrated and following medical guidance can help keep things steady. For family and friends, the main effect is offering support during checkups and sharing reassurance that, in most cases, this condition is benign and compatible with a full, active life.
Treatment and drugs
Treatment for dicarboxylic aminoaciduria focuses on easing symptoms and preventing complications, since there’s no specific cure to “fix” the underlying transport problem in the kidneys. Most people don’t need strong medicines; care often includes good hydration, a balanced diet with regular meals to avoid long fasts, and prompt treatment of illnesses that could trigger low blood sugar. Doctors may check growth, development, and kidney health over time, and they might suggest nutrition support if feeding difficulties or poor weight gain occur. If seizures, low blood sugar, or metabolic stress appear, hospital care with glucose and supportive measures can help stabilize things quickly. Supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Living well with dicarboxylic aminoaciduria often centers on daily routines—what you eat, drink, and how you support development at home and school. Beyond prescriptions, supportive therapies can protect kidney health, support growth, and help learning and behavior. A dietitian and therapy team can tailor plans as needs change over time. For some families, spotting early symptoms of dicarboxylic aminoaciduria—such as feeding challenges or developmental delays—helps them start these supports sooner.
A registered dietitian can help plan balanced meals that meet protein needs without overdoing certain additives. They can adjust plans for age, growth, and activity.
Aim for steady, moderate protein across the day rather than large, high-protein meals. This can ease the body’s handling of certain amino acids.
Some people do better limiting foods high in flavor enhancers like MSG, which contain glutamate. Reading labels and choosing simple, minimally processed foods can make this easier.
Avoid long fasting periods by eating on a schedule. Steady fuel can reduce metabolic stress and support energy.
Your genes may have an impact on how drugs work for you
Medicines for dicarboxylic aminoaciduria can work differently from person to person because gene changes may alter drug processing enzymes and transporters. Pharmacogenetic testing, when available, can guide safer dosing and medication choice, alongside careful clinical monitoring.
Pharmacological treatments
Dicarboxylic aminoaciduria does not have a disease-specific medication. Most people don’t need drug treatment, even when early symptoms of Dicarboxylic aminoaciduria lead to testing. Medicines are considered only if related issues show up (for example, kidney stones) or if there are separate, coexisting conditions that need care. Ask your doctor why a specific drug was recommended for you.
Potassium citrate can make urine less acidic and may help lower the chance of certain kidney stones. Your clinician will tailor the dose and monitor kidney function and potassium levels.
Ibuprofen or naproxen can ease cramping pain during a stone episode. Use the lowest effective dose for the shortest time and avoid if you have kidney disease or stomach ulcers.
Levetiracetam or lamotrigine may be used if seizures are present for any reason. Drug choice depends on seizure type, age, other medicines, and side effect profile.
Sertraline or fluoxetine are common selective serotonin reuptake inhibitors that can reduce obsessive-compulsive or anxiety symptoms if they coexist. Doses are started low and adjusted gradually based on response and tolerability.
Genetic influences
In most people, this condition stems from inherited changes in a single gene that helps the kidneys take back the amino acids glutamate and aspartate instead of losing them in urine. With Dicarboxylic aminoaciduria, a “carrier” means you hold the gene change but may not show symptoms. When both parents carry one changed copy, each child has a 25% chance of having Dicarboxylic aminoaciduria, a 50% chance of being a carrier, and a 25% chance of having neither copy changed. The impact can differ from person to person; for some, the only clue is a lab finding of extra glutamate and aspartate in urine. Because early symptoms of Dicarboxylic aminoaciduria can be subtle or even absent, noticing a pattern in relatives and discussing genetic testing can be helpful. Pinpointing the specific gene change, often in a gene called SLC1A1, can guide monitoring for you and inform testing options for family members.
Is Dicarboxylic aminoaciduria genetic?
Genetics are central in Dicarboxylic aminoaciduria; it’s an inherited condition caused by changes in a gene that transports certain amino acids in the kidneys. Variants are usually passed in an autosomal recessive pattern. Genetic testing can confirm the diagnosis and guide family counseling.
Pharmacogenetics—how genetics influence drug effects
Because dicarboxylic aminoaciduria comes from inherited changes in a transporter that moves the amino acids glutamate and aspartate in the gut and kidneys, it mainly affects absorption and urinary loss rather than how most medicines are broken down. As a result, there are no condition‑specific drug–gene dosing rules, and treatment of dicarboxylic aminoaciduria tends to focus on nutrition, growth, and managing any related symptoms. If supplements or higher‑protein foods are tried, the same transport issue can limit what your body keeps, so dosing, timing, and lab checks may need to be personalized. When medicines are used for associated issues such as seizures, attention, or mood, your care team may look at common pharmacogenetic markers that influence liver enzyme activity to guide the choice and dose, but these tests are not specific to dicarboxylic aminoaciduria. Alongside your medical history and current medications, genetic testing can help your team decide whether to try certain therapies, how to monitor for side effects, and when to adjust a dose. Other factors—such as age, nutrition, overall kidney and liver health, and interactions with other drugs—also shape how you respond, so decisions are based on the whole picture rather than genetics alone.
Interactions with other conditions
Managing Dicarboxylic aminoaciduria alongside other health issues mostly becomes important when the kidneys or nutrition are also affected. If someone also has a kidney tubule problem (such as Fanconi syndrome) or chronic kidney disease, the unusual amino acid losses seen in Dicarboxylic aminoaciduria may look more pronounced and can complicate lab interpretation and care plans. To understand overall health, it’s useful to see how conditions overlap. Neurologic or mental health conditions such as epilepsy or obsessive–compulsive disorder have been reported in some families with gene changes linked to Dicarboxylic aminoaciduria, but not everyone is affected, and having one does not prove it causes the other. When conditions that limit intake or absorption are present—like eating disorders, severe vomiting, or untreated celiac disease—low dietary protein may make fatigue or other early symptoms of Dicarboxylic aminoaciduria harder to tease apart from the second condition. With coordinated care across kidney, nutrition, and neurology or mental health teams when needed, most people with Dicarboxylic aminoaciduria do well, and treatments for coexisting illnesses can be used safely with routine monitoring.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of children who were slow to gain strength, had frequent tummy troubles, or didn’t seem to grow as expected, even when food was available. Caregivers tried different diets, and some children improved a little while others did not. These observations hinted that something about processing certain nutrients was different, long before lab tests could show why.
From early theories to modern research, the story of dicarboxylic aminoaciduria has moved from scattered case descriptions to a clearer picture tied to a specific transporter in the kidney and gut. Mid-20th-century reports described unusual amounts of particular amino acids in urine samples from otherwise varied patients. At first, doctors only had the lab clue—excess amino acids spilling into urine—without a unifying explanation for symptoms like poor growth, fatigue, or mild developmental delays in some, and no symptoms at all in others.
As amino acid chromatography and later mass spectrometry became common, more clinics could spot the same urinary pattern. This shifted dicarboxylic aminoaciduria from a curiosity to a recognizable metabolic transport condition. Initially understood only through symptoms, later work showed that the kidneys were not reclaiming certain amino acids efficiently, and the intestine might also absorb them less effectively. Researchers began to connect the dots: when these building blocks are lost in urine or not absorbed well, nutrition and energy balance can be affected, especially in infancy and early childhood.
Advances in genetics then identified changes in a gene that acts like a gate for specific amino acids, clarifying why the condition could run in families and follow an autosomal recessive pattern. DNA research now explains how different variants can lead to a wide range of outcomes—from people who feel well and are found only through urine testing, to those with growth or developmental concerns that bring them to medical care. Not every early description was complete, yet together they built the foundation of today’s knowledge.
With newborn screening expanding for other metabolic disorders, clinicians also learned when dicarboxylic aminoaciduria does and does not appear on standard panels, helping refine how and when to look for it. Over time, the condition’s history has emphasized careful nutrition, monitoring of growth and development, and tailored support rather than a one-size-fits-all approach.
Today, the history of dicarboxylic aminoaciduria reflects steady progress: better testing, clearer genetic understanding, and more nuanced care. Looking back helps explain why experiences vary so much between individuals and why a precise diagnosis matters for planning follow-up and supporting everyday health.